A Comparative Clinical Study to Evaluate the Effects of Kunjal Kriya and Lajasattu in the Management of Hyperacidity Amlapitta

A RANDOMIZED OPEN LABEL COMPARATIVE CLINICAL STUDY TO ASSESS THE EFFECT OF KUNJAL KRIYA AND LAJASATTU IN AMLAPITTA HYPERACIDITY - NIL

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101607

Enrollment

Registered

2026-01-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K318- Other specified diseases of stomach and duodenum

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having classical symptoms of Amlapitta. Patients of either sex and between 20-40 years of age Patients willing and able to carry out treatment for 4 weeks Patients will be registered with duly signed informed consent prior to the trial

Exclusion criteria

Exclusion criteria: Patients with diagnosed cases of gastric, peptic and duodenal ulcers Patients with any GIT abdominal complications and chronic illnes Patient taking drug such as NSAIDs which is supposed to increase acid production and gastric ulcerations History of esophageal varices and hematemesis Patients not willing to participate in a clinical study Pregnant and lactating women are avoided for study

Design outcomes

Primary

Measure	Time frame
It will be assessed on the basis of statistical analysis applied on subjective parameter after completion of trialTimepoint: 4 weeks	—

Secondary

Measure	Time frame
Improvement in quality of life Safety & tolerability of Kunjal Kriya and LajasattuTimepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDr Ravi Pawar

Institute for ayurved studies and Research

ravip3414@gmail.com8149596759

Outcome results